|
|
|
|
| LEADER |
01113cam a2200301 u 4500 |
| 001 |
10090003 |
| 003 |
upatras |
| 005 |
20210303084156.0 |
| 008 |
110701s2008 eng |
| 020 |
|
|
|a 9780470403587
|
| 020 |
|
|
|a 0470403586
|
| 040 |
|
|
|a GR-PaULI
|c GR-PaULI
|
| 041 |
0 |
|
|a eng
|
| 082 |
1 |
4 |
|a 615.19
|2 22
|
| 100 |
1 |
|
|a Ng, Rick
|9 93202
|
| 245 |
1 |
0 |
|a Drugs
|h [electronic resource]
|b from discovery to approval
|c Rick Ng
|
| 250 |
|
|
|a 2nd ed
|
| 260 |
|
|
|a Hoboken, NJ
|b John Wiley & Sons
|c c2009
|
| 300 |
|
|
|a p
|c εκ
|
| 504 |
|
|
|a Περιέχει βιβλιογραφικές παραπομπές και ευρετήριο
|
| 650 |
|
4 |
|a Φαρμακοβιομηχανία
|9 93203
|
| 650 |
|
4 |
|a Φαρμακευτική τεχνολογία
|9 36666
|
| 710 |
2 |
|
|a Wiley InterScience (Online service)
|9 93164
|
| 852 |
|
|
|a GR-PaULI
|b ΠΑΤΡΑ
|b ΒΚΠ
|h 615/.19 NG
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1002/9780470403587
|
| 942 |
|
|
|2 ddc
|
| 952 |
|
|
|0 0
|1 0
|4 0
|6 615_000000000000000__19_NG
|7 0
|9 97827
|a LISP
|b LISP
|d 2016-04-24
|l 0
|o 615/.19 NG
|r 2016-04-24 00:00:00
|w 2016-04-24
|y ERS
|x Wiley E-Books
|
| 999 |
|
|
|c 65707
|d 65707
|
